Search for other works by this author on: ...

Ariel University, Ari'el, Israel.

Telix Pharmaceuticals announced that TLX101 (131 I-iodofalan) increased median overall survival (OS) for patients with high-grade glioma, when compared against median OS without the drug. In the phase ...

10Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China. 11National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, ...

Copyright held by the owner/author(s).

Novartis announced it will spend $23 billion to construct and expand facilities in the United States. The planned investment includes six new manufacturing plants, including two radioligand therapy ...

This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license.

1Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, Virginia.

1Department of Pathology, Renaissance School of Medicine, Stony Brook University, Stony Brook, New York.

1Manchester Cancer Research Centre (MCRC), Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom.

1State Key Laboratory of Oral and Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School and Hospital of ...

1Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. 2Division of Life Sciences and Medicine, Department of Urology, the First Affiliated ...